- Home
- FCO vs OVID Comparison
FCO vs OVID Comparison
Compare FCO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- OVID
- Stock Information
- Founded
- FCO 1991
- OVID 2014
- Country
- FCO United Kingdom
- OVID United States
- Employees
- FCO N/A
- OVID N/A
- Industry
- FCO Investment Managers
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- FCO Finance
- OVID Health Care
- Exchange
- FCO Nasdaq
- OVID Nasdaq
- Market Cap
- FCO 85.6M
- OVID 88.9M
- IPO Year
- FCO N/A
- OVID 2017
- Fundamental
- Price
- FCO $2.91
- OVID $1.72
- Analyst Decision
- FCO
- OVID Strong Buy
- Analyst Count
- FCO 0
- OVID 4
- Target Price
- FCO N/A
- OVID $3.13
- AVG Volume (30 Days)
- FCO 100.1K
- OVID 5.1M
- Earning Date
- FCO 01-01-0001
- OVID 11-11-2025
- Dividend Yield
- FCO 14.96%
- OVID N/A
- EPS Growth
- FCO N/A
- OVID N/A
- EPS
- FCO 0.43
- OVID N/A
- Revenue
- FCO N/A
- OVID $6,651,000.00
- Revenue This Year
- FCO N/A
- OVID $1,086.57
- Revenue Next Year
- FCO N/A
- OVID N/A
- P/E Ratio
- FCO $12.30
- OVID N/A
- Revenue Growth
- FCO N/A
- OVID 1070.95
- 52 Week Low
- FCO $4.73
- OVID $0.24
- 52 Week High
- FCO $6.63
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- FCO 10.15
- OVID 63.50
- Support Level
- FCO $2.88
- OVID $1.24
- Resistance Level
- FCO $3.13
- OVID $2.01
- Average True Range (ATR)
- FCO 0.09
- OVID 0.20
- MACD
- FCO 0.06
- OVID 0.03
- Stochastic Oscillator
- FCO 7.19
- OVID 66.29
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.